Ironshore to Present Data From a Pivotal Trial of JORNAY PM™ (methylphenidate HCl) CII at the 31st Annual International Conference on ADHD
Attendees are encouraged to visit Ironshore representatives at Booths 210 & 309 to learn more about JORNAY PM.
- Attendees are encouraged to visit Ironshore representatives at Booths 210 & 309 to learn more about JORNAY PM.
- Ironshore is proud to be a premier sponsor of the largest conference on ADHD, said Dr. Randy Sallee, Ironshores Chief Medical Officer.
- The Annual International Conference on ADHD is the largest conference on ADHD and brings together various audiences affected by or involved in the treatment of ADHD, including clinicians, ADHD coaches, educators, advocates, parents and caregivers of children with ADHD and adults with ADHD.
- The conference is hosted by Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD), Attention Deficit Disorder Association (ADDA) and ADHD Coaches Organization (ACO).